Alginate and Lactulose drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Alginate (algin) and Lactulose (lactulose). Common drug interactions include cognitive disorder among females and nausea among males.

The phase IV clinical study analyzes what interactions people have when they take Alginate and Lactulose. It is created by eHealthMe based on reports of 72 people who take the same drugs from the FDA, and is updated regularly.

What is Alginate?

Alginate has active ingredients of algin. eHealthMe is studying from 1,556 Alginate users. Check the latest studies of Alginate.

What is Lactulose?

Lactulose has active ingredients of lactulose. It is often used in constipation. eHealthMe is studying from 46,960 Lactulose users. Check the latest studies of Lactulose.



On Aug, 09, 2026

72 people who take Alginate and Lactulose together, and have interactions are studied.

Alginate and Lactulose drug interactions.

What are the common drug interactions of Alginate and Lactulose, by gender? *:

female:

  1. Cognitive disorder (mental health disorders affects learning, memory, perception, and problem solving)
  2. Dehydration (dryness resulting from the removal of water)
  3. Device expulsion
  4. Diplopia (double vision)
  5. Disturbance in attention
  6. Drug abuse
  7. Dry skin
  8. Dyspnoea (difficult or laboured respiration)
  9. Eye pruritus (eye itching)
  10. Facial pain

male:

  1. Nausea (feeling of having an urge to vomit)
  2. Diarrhoea
  3. Hypertension (high blood pressure)
  4. Oedema peripheral (superficial swelling)
  5. Pruritus (severe itching of the skin)
  6. Stomatitis (inflammation of mucous membrane of mouth)
  7. Agitation (state of anxiety or nervous excitement)
  8. Blood phosphorus decreased
  9. Dry mouth
  10. Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)

What are the common drug interactions of Alginate and Lactulose, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Ascites (accumulation of fluid in the abdominal cavity)
  2. Decreased appetite
  3. Diarrhoea
  4. Face oedema (swelling of face)
  5. Fatigue (feeling of tiredness)
  6. Haemoglobin decreased
  7. Hypertension (high blood pressure)
  8. Nausea (feeling of having an urge to vomit)
  9. Oedema peripheral (superficial swelling)
  10. Palmar-plantar erythrodysaesthesia syndrome (hand-foot syndrome)

30-39:

  1. Anaemia (lack of blood)
  2. Neutropenia (an abnormally low number of neutrophils)
  3. Rash
  4. Upper respiratory tract infection
  5. Weight decreased

40-49:

  1. Abdominal pain
  2. Agitation (state of anxiety or nervous excitement)
  3. Blood phosphorus decreased
  4. Chest pain
  5. Death
  6. Dry mouth
  7. Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
  8. Nausea (feeling of having an urge to vomit)
  9. Urinary retention (the inability to completely or partially empty the bladder)
  10. Vomiting

50-59:

  1. Hepatic failure (liver failure)
  2. Pneumonitis (inflammation of the walls of the alveoli in the lungs)
  3. Pulmonary embolism (blockage of the main artery of the lung)
  4. Small intestinal obstruction (blockage in small intestine)
  5. Surgery
  6. Hyponatraemia (abnormally low level of sodium in the blood; associated with dehydration)
  7. Gingivitis (inflammation of gums)
  8. Lower respiratory tract infection
  9. Oral herpes (viral infection of mouth)
  10. Tooth abscess (pus formation in tooth)

60+:

  1. Diarrhoea
  2. Nausea (feeling of having an urge to vomit)
  3. Face oedema (swelling of face)
  4. Haemoglobin decreased
  5. Hypertension (high blood pressure)
  6. Oedema peripheral (superficial swelling)
  7. Photopsia (presence of perceived flashes of light)
  8. Renal failure (kidney dysfunction)
  9. Stomatitis (inflammation of mucous membrane of mouth)
  10. Vitreous floaters (spots before the eyes)

What are the existing conditions these people have? *

  1. Pain: 16 people, 22.22%
  2. High Blood Pressure: 12 people, 16.67%
  3. Abdominal Pain: 11 people, 15.28%
  4. Indigestion: 9 people, 12.50%
  5. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 9 people, 12.50%
  6. Depression: 8 people, 11.11%
  7. Nausea (feeling of having an urge to vomit): 8 people, 11.11%
  8. Chest Pain: 7 people, 9.72%
  9. Diabetes: 6 people, 8.33%
  10. Hypotension (abnormally low blood pressure): 6 people, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Alginate and Lactulose?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Alginate and Lactulose:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Alginate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Lactulose:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Alginate and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Lactulose and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on algin and lactulose (the active ingredients of Alginate and Lactulose, respectively), and Alginate and Lactulose (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: